Derovan Netanel 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Aug 1, 2022
Insider Transaction Report
Form 4
Derovan Netanel
Chief Legal Officer
Transactions
- Award
Common Stock
2022-07-28+30,000→ 48,000 total
Footnotes (1)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.